129 related articles for article (PubMed ID: 21585427)
1. Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients.
Mackenzie KA; Miller AP; Hock BD; Gardner J; Simcock JW; Roake JA; Dachs GU; Robinson BA; Currie MJ
Histopathology; 2011 May; 58(6):875-85. PubMed ID: 21585427
[TBL] [Abstract][Full Text] [Related]
2. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: a single-center experience in São Paulo, Brazil.
Hayashida MZ; Fernandes VM; Fernandes DR; Ogawa MM; Tomimori J
Int J Dermatol; 2015 Oct; 54(10):e383-8. PubMed ID: 25969871
[TBL] [Abstract][Full Text] [Related]
4. COX-2 expression correlates with microvessel density in non-melanoma skin cancer from renal transplant recipients and immunocompetent individuals.
O'Grady A; O'Kelly P; Murphy GM; Leader M; Kay E
Hum Pathol; 2004 Dec; 35(12):1549-55. PubMed ID: 15619216
[TBL] [Abstract][Full Text] [Related]
5. CD34 microvessel density and VEGF expression in basal and squamous cell carcinoma.
Loggini B; Boldrini L; Gisfredi S; Ursino S; Camacci T; De Jeso K; Cervadoro G; Pingitore R; Barachini P; Leocata P; Fontanini G
Pathol Res Pract; 2003; 199(11):705-12. PubMed ID: 14708636
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
Mokos M; Bašić-Jukić N
Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
[TBL] [Abstract][Full Text] [Related]
7. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
8. Expression of Bcl-xL and Mcl-1 in the nonmelanoma skin cancers of renal transplant recipients.
Burke MT; Morais C; Oliver KA; Lambie DL; Gobe GC; Carroll RP; Staatz CE; Sinnya S; Soyer HP; Winterford C; Haass NK; Campbell SB; Isbel NM
Am J Clin Pathol; 2015 Apr; 143(4):514-26. PubMed ID: 25780003
[TBL] [Abstract][Full Text] [Related]
9. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
10. Microvessel density and VEGF expression seems to correlate with invasiveness of basal cell carcinoma.
Carbone A; Viola P; Varrati S; Angelucci D; Tulli A; Amerio P
Eur J Dermatol; 2011; 21(4):608-9. PubMed ID: 21865111
[No Abstract] [Full Text] [Related]
11. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
[TBL] [Abstract][Full Text] [Related]
12. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.
Blokx WA; de Jong EM; de Wilde PC; Bulten J; Link MM; Ruiter DJ; van de Kerkhof PC
Mod Pathol; 2003 Sep; 16(9):869-78. PubMed ID: 13679450
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factors in OSCC.
Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Barros-Angueira F; Gándara-Rey JM; García-García A
Cancer Lett; 2011 Dec; 313(1):1-8. PubMed ID: 21959110
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
[TBL] [Abstract][Full Text] [Related]
15. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
[TBL] [Abstract][Full Text] [Related]
16. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
17. Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations.
Gutiérrez-Dalmau A; Revuelta I; Ferrer B; Mascaró JM; Oppenheimer F; Albanell J; Campistol JM
Transplantation; 2010 Nov; 90(9):986-92. PubMed ID: 20844469
[TBL] [Abstract][Full Text] [Related]
18. Differences in the vascular patterns of basal and squamous cell skin carcinomas explain their differences in clinical behaviour.
Chin CW; Foss AJ; Stevens A; Lowe J
J Pathol; 2003 Jul; 200(3):308-13. PubMed ID: 12845626
[TBL] [Abstract][Full Text] [Related]
19. Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation.
Jensen R; Lee J
Neurosurgery; 2012 Jul; 71(1):146-56. PubMed ID: 22472549
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
